These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12912792)

  • 1. Plaque rupture, lysophosphatidic acid, and thrombosis.
    Spector AA
    Circulation; 2003 Aug; 108(6):641-3. PubMed ID: 12912792
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G; Siess W; Essler M
    Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family.
    Tigyi G
    Mol Pharmacol; 2001 Dec; 60(6):1161-4. PubMed ID: 11723220
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
    Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular localization of oxidized low-density lipoproteins in atherosclerotic plaque cells revealed by electron microscopy combined with laser capture microdissection.
    Bobryshev YV
    J Histochem Cytochem; 2005 Jun; 53(6):793-7. PubMed ID: 15928330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes.
    Kotarsky K; Boketoft A; Bristulf J; Nilsson NE; Norberg A; Hansson S; Owman C; Sillard R; Leeb-Lundberg LM; Olde B
    J Pharmacol Exp Ther; 2006 Aug; 318(2):619-28. PubMed ID: 16651401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding.
    Kingsbury MA; Rehen SK; Contos JJ; Higgins CM; Chun J
    Nat Neurosci; 2003 Dec; 6(12):1292-9. PubMed ID: 14625558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of lysophosphatidic acid action.
    Tigyi G; Parrill AL
    Prog Lipid Res; 2003 Nov; 42(6):498-526. PubMed ID: 14559069
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of platelets and endothelial cells by mildly oxidized LDL proceeds through activation of lysophosphatidic acid receptors and the Rho/Rho-kinase pathway. Inhibition by lovastatin.
    Essler M; Retzer M; Bauer M; Zangl KJ; Tigyi G; Siess W
    Ann N Y Acad Sci; 2000 Apr; 905():282-6. PubMed ID: 10818465
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we stabilize unstable plaque?
    Paoletti R; Cignarella A
    Curr Atheroscler Rep; 2003 Nov; 5(6):423-4. PubMed ID: 14525673
    [No Abstract]   [Full Text] [Related]  

  • 13. Rupture of the atherosclerotic plaque: does a good animal model exist?
    Cullen P; Baetta R; Bellosta S; Bernini F; Chinetti G; Cignarella A; von Eckardstein A; Exley A; Goddard M; Hofker M; Hurt-Camejo E; Kanters E; Kovanen P; Lorkowski S; McPheat W; Pentikäinen M; Rauterberg J; Ritchie A; Staels B; Weitkamp B; de Winther M;
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):535-42. PubMed ID: 12615660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for ozone formation in human atherosclerotic arteries.
    Wentworth P; Nieva J; Takeuchi C; Galve R; Wentworth AD; Dilley RB; DeLaria GA; Saven A; Babior BM; Janda KD; Eschenmoser A; Lerner RA
    Science; 2003 Nov; 302(5647):1053-6. PubMed ID: 14605372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiological role of lysophosphatidic acid and its relevancephysiological role of lysophosphatidic acid and its relevance to diseases].
    Shimizu Y; Tokumura A
    Seikagaku; 2011 Jun; 83(6):506-17. PubMed ID: 21800681
    [No Abstract]   [Full Text] [Related]  

  • 16. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidised LDL and progression of atherosclerosis.
    Laakso M; Poikolainen K; Pyörälä K
    Lancet; 1992 Jul; 340(8813):234; author reply 236. PubMed ID: 1353148
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative myocardial ischemia and infarction. Atherosclerotic plaque rupture in coronary artery disease.
    Buffington CW; Perez WJ
    Int Anesthesiol Clin; 1992; 30(1):217-35. PubMed ID: 1577540
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of atherosclerotic plaque development and rupture: an overview.
    Rohde LE; Lee RT
    Semin Vasc Med; 2003 Nov; 3(4):347-54. PubMed ID: 15199441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
    Spiel AO; Gilbert JC; Jilma B
    Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.